1. Guo, Tengxiao, Wang, Yuxia, Sun, Xiaolu, Yuan, Weiping, Wang, Xiaomin. 2024. Loss of RNA-binding protein CELF2 promotes acute leukemia development via FAT10-mTORC1. In Oncogene, 43, 1476-1487. doi:10.1038/s41388-024-03006-3. https://pubmed.ncbi.nlm.nih.gov/38514854/
2. Turchi, Laurent, Sakakini, Nathalie, Saviane, Gaelle, Burel-Vandenbos, Fanny, Virolle, Thierry. 2023. CELF2 Sustains a Proliferating/OLIG2+ Glioblastoma Cell Phenotype via the Epigenetic Repression of SOX3. In Cancers, 15, . doi:10.3390/cancers15205038. https://pubmed.ncbi.nlm.nih.gov/37894405/
3. Lai, Shihui, Wang, Yan, Li, Ting, Zhang, Xiang, Lin, Chengjie. 2022. N6-methyladenosine-mediated CELF2 regulates CD44 alternative splicing affecting tumorigenesis via ERAD pathway in pancreatic cancer. In Cell & bioscience, 12, 125. doi:10.1186/s13578-022-00844-0. https://pubmed.ncbi.nlm.nih.gov/35941702/
4. Yeung, Yiu To, Fan, Suyu, Lu, Bingbing, Bode, Ann M, Dong, Zigang. . CELF2 suppresses non-small cell lung carcinoma growth by inhibiting the PREX2-PTEN interaction. In Carcinogenesis, 41, 377-389. doi:10.1093/carcin/bgz113. https://pubmed.ncbi.nlm.nih.gov/31241130/
5. Ramalingam, Satish, Ramamoorthy, Prabhu, Subramaniam, Dharmalingam, Anant, Shrikant. . Reduced Expression of RNA Binding Protein CELF2, a Putative Tumor Suppressor Gene in Colon Cancer. In Immuno-gastroenterology, 1, 27-33. doi:. https://pubmed.ncbi.nlm.nih.gov/23795348/
6. Sah, Bindeshwar, Singh, Jasvinder, Shen, Yao, Geskin, Larisa J, Liu, Liang. 2024. Loss of CELF2 promotes skin tumorigenesis and increases drug resistance. In International journal of dermatology, 64, 101-110. doi:10.1111/ijd.17295. https://pubmed.ncbi.nlm.nih.gov/38887832/
7. Guo, Qinhao, Wu, Yong, Guo, Xueqi, Ju, Xingzhu, Wu, Xiaohua. 2020. The RNA-Binding Protein CELF2 Inhibits Ovarian Cancer Progression by Stabilizing FAM198B. In Molecular therapy. Nucleic acids, 23, 169-184. doi:10.1016/j.omtn.2020.10.011. https://pubmed.ncbi.nlm.nih.gov/33335801/
智鼠故事 
